Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Xun Zhao, DeJun Cui, WenQiang Yuan, Chen Chen & Qi Liu. (2022) Berberine represses Wnt/β-catenin pathway activation via modulating the microRNA-103a-3p/Bromodomain-containing protein 4 axis, thereby refraining pyroptosis and reducing the intestinal mucosal barrier defect induced via colitis. Bioengineered 13:3, pages 7392-7409.
Read now
Read now
Articles from other publishers (7)
Mingyan Li, Yaling Wang, Lingzhi Zhang, Changxing Gao, Jing J. Li, Jiandong Jiang & Qing Zhu. (2023) Berberine improves central memory formation of CD8+ T cells: Implications for design of natural product-based vaccines. Acta Pharmaceutica Sinica B 13:5, pages 2259-2268.
Crossref
Crossref
Ya-Fei Liu, Huan-Huan Wang, Yin-Hong Geng, Liang Han, Sheng-Hao Tu & Hui Wang. (2023) Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism. Frontiers in Pharmacology 14.
Crossref
Crossref
Weiping Bao, Hongping Sun, Xiang Wu, Juan Xu, Huifeng Zhang, Lin Cao & Yaofu Fan. (2022) Exploring Anti-Type 2 Diabetes Mellitus Mechanism of Gegen Qinlian Decoction by Network Pharmacology and Experimental Validation. Disease Markers 2022, pages 1-12.
Crossref
Crossref
Jia Xu, Yining Zhang, Zhiyi Yu, Yueqi Guan, Yuqian Lv, Meishuang Zhang, Ming Zhang, Li Chen, Xiaoyan Lv & Fengying Guan. (2022) Berberine mitigates hepatic insulin resistance by enhancing mitochondrial architecture via the SIRT1/Opa1 signalling pathway. Acta Biochimica et Biophysica Sinica 54:10, pages 1464-1475.
Crossref
Crossref
Ying Dai, Xudan Ma, Jiangnan Zhang, Shuting Yu, Yuchao Zhu & Jianhua Wang. (2022)
hsa_circ_0115355 promotes pancreatic β‐cell function in patients with type 2 diabetes through the
miR
‐145/
SIRT1
axis
. Journal of Clinical Laboratory Analysis 36:8.
Crossref
Crossref
Usman Sabir, Hafiz Muhammad Irfan, Alamgeer, Ihtisham Umer, Zahid Rasul Niazi & Hafiz Muhammad Mazhar Asjad. (2022) Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways. Naunyn-Schmiedeberg's Archives of Pharmacology 395:7, pages 741-755.
Crossref
Crossref
Yu‐Huan Peng, Ping Wang, Xiao‐Qun He, Ming‐Zhao Hong & Feng Liu. (2021) Micro ribonucleic acid‐363 regulates the phosphatidylinositol 3‐kinase/threonine protein kinase axis by targeting NOTCH1 and forkhead box C2, leading to hepatic glucose and lipids metabolism disorder in type 2 diabetes mellitus. Journal of Diabetes Investigation 13:2, pages 236-248.
Crossref
Crossref